Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug 20/05/2015 by Intellectual Property Watch Leave a Comment Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead’s patent applications in five emerging economies.
Statement: Blumenthal Offers Amendment On Trade Transparency 19/05/2015 by Intellectual Property Watch Leave a Comment Senators Blumenthal, Brown, Baldwin, and Udall introduced today a trade negotiation transparency bill that would require that all formal U.S. proposals for trade agreement restrictions on domestic regulations be posted on a website. This is a common sense policy that should be broadly supported. The bill would require policies similar to the transparency policies currently followed by the European Union and by intergovernmental organizations that set similar minimum regulatory standards. But it would be a major change in the current process for trade negotiations followed by the U.S. Trade Representative, which are infamously secretive, write Sean Flynn and David Levine.
WHA68: Global Vaccine Plan Lagging; New Proposal To Lower Prices 19/05/2015 by William New, Intellectual Property Watch 2 Comments An assessment of the World Health Organization Global Vaccine Action Plan aimed at delivering vaccination to all and boosting research into new vaccines found implementation to be “far off-track” in some areas. Today at the World Health Assembly, Libya put forward a new proposal at the Assembly to reduce vaccine prices and increase availability in developing countries.
World Health Assembly Opens: Time Of Change At WHO; G-7 Involved 18/05/2015 by William New, Intellectual Property Watch 2 Comments “The Ebola outbreak shook this organization to its core,” World Health Organization Director General Margaret Chan said in opening the WHO’s annual assembly today. And the need to better construct the world’s emergency response systems has the biggest economies on the podium, with German Chancellor Angela Merkel speaking as chair of the Group of 7.
WHO Leads Effort To Build R&D Roadmap For Future Epidemics 15/05/2015 by William New, Intellectual Property Watch Leave a Comment The World Health Organization is working to learn from the fast response on research and development for Ebola that led to effective treatments in a short time. It hopes that this changes the way R&D for emergency vaccines is done forever.
Polish Government Drafts IP Law Reform 13/05/2015 by Jaroslaw Adamowski for Intellectual Property Watch Leave a Comment WARSAW — More than twenty years after Poland’s parliament passed the Authors’ and Related Rights law of 1994, the Polish government is drafting three bills to modify the country’s intellectual property legislation. The first of the drafts prepared by the Polish Ministry of Culture and National heritage was submitted to the Parliament in March, and is currently being deliberated, while the ministry is finishing work on the remaining two drafts.
In ‘Huge’ Move, WHO Adds Key Hepatitis C, Cancer, TB Drugs To Essential Medicines List 08/05/2015 by William New, Intellectual Property Watch 2 Comments The World Health Organization today published its updated Model List of Essential Medicines, including high-priced new treatments for hepatitis C, cancers and multi-drug resistant tuberculosis (MDR-TB) that were quickly applauded by the public health advocacy community.
EU Trade Commissioner New Paper On Investor-State Disputes In TTIP 05/05/2015 by Intellectual Property Watch Leave a Comment EU Trade Commissioner Cecilia Malmström published a concept paper on investor-state dispute settlement (ISDS) mechanisms to be included in the Trans-Atlantic Trade and Investment Partnership (TTIP).
Are You Looking To Sell Your Patent To Google? 01/05/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment From 8-22 May, US online search giant Google will open a streamlined portal for patent owners to let Google know about patents they are willing to sell at a price they set.
Industry Asks For Clarity On LDC Request To Extend TRIPS Pharma Waiver 01/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Least developed countries (LDCs) at the World Trade Organization have requested that a waiver allowing them to not enforce intellectual property rights on pharmaceutical products be extended beyond its deadline of 1 January 2016. The brand pharmaceutical industry this week stated that it supports access to medicines for LDCs but does not see the need for this extension as LDCs already benefit from a WTO waiver on all products until 2021.